Journal list menu
Export Citations
Download PDFs
Sarcoma
Prognostic impact of circulating tumor cells in patients with soft-tissue sarcomas: a prospective study
- First Published: 03 February 2023
The diagnosis, classification, and treatment of sarcoma in this era of artificial intelligence and immunotherapy
- First Published: 19 October 2022
Gene expression profiling improves prognostication by nomogram in patients with soft-tissue sarcomas
- First Published: 07 February 2022
Establishment of an orthotopic perirenal space xenograft mouse model of retroperitoneal sarcoma
- First Published: 13 May 2021
A nomogram for predicting overall survival in patients with low-grade endometrial stromal sarcoma: A population-based analysis
- First Published: 18 June 2020
Treatment and prognosis of iliac fossa soft tissue sarcoma: A single-center study
- First Published: 27 May 2020
Clinical outcomes of angiosarcoma: a single institution experience
- First Published: 06 August 2019
Primary intrathoracic liposarcoma: a clinical analysis of 31 cases
- First Published: 02 April 2019
Sign up for email alerts
Tools
More from this journal
Cancer collection based on different tumor types
Information for Authors
Cancer Communications offers waivers to authors for selected high quality articles. For rapid feedback on the potential suitability of an article for waiver, please send a pre-submission enquiry to the editorial office, providing the article title, abstract and a brief cover letter.
Impact Factors in Journal Citation Report (2018, Clarivate) are under the previous journal title Chinese Journal of Cancer.
Archival Content
To browse articles published in the journal prior to March 2015, please visit the Sun Yat-sen University Cancer Center website.
Understanding Open Access
As an open access journal, all articles in Cancer Communications are freely available to read, download and share immediately on publication.
Relevant Open – Access Health Sciences journals
Aging AND Cancer (2020-Present)
Cancer Innovation (2022-Present)
Clinical and Translational Medicine (2012-Present)
MedComm (2020-Present)
MedComm – Oncology (2022-Present)